The purpose of this study was to examine whether exercise training, superimposed on compensated-concentric hypertrophy, could increase myocardial hypoperfusion-reperfusion (H/R) tolerance. Female Wistar-Kyoto (WKY) and spontaneously hypertensive rats (SHR) (age:4 months; N=40), were placed into a sedentary (SED) or exercise training (TRD) group (treadmill running; 25 m/min, 1 hr/d, 5 d/wk for 16 wks). Four groups were studied: (WKY-SED, n=10), (WKY-TRD, n=10), (SHR-SED, n=10), (SHR-TRD, n=10). Blood pressure and heart rate were determined and in vitro isolated heart performance was measured with a retrogradely perfused, Langendorff, isovolumic preparation. The H/R protocol consisted of a 75% reduction in coronary flow for 17 min followed by 30 min of reperfusion. Although the rate-pressure product (RPP) was significantly elevated in SHR relative to WKY, traininginduced bradycardia with TRD reduced the RPP in SHR-TRD (P<0.05) without an attenuation in systolic blood pressure. Heart/body weight ratio was greater in both groups of SHR vs. WKY-SED (P<0.001). Absolute and relative myocardial tolerance to H/R was greater in WKY-TRD and both groups of SHR relative to WKY-SED (P<0.05). Endurance training superimposed on hypertension-induced compensated hypertrophy conferred no further cardioprotection to H/R. Post-reperfusion HSP72 abundance was enhanced in WKY-TRD and both groups of SHR relative to WKY-SED (P<0.05) and was highly correlated with absolute LV functional recovery during reperfusion (R 2 =0.86, P<0.0001). These data suggest both compensated hypertrophy associated with short-term hypertension and endurance training individually improved H/R and that increased post-reperfusion HSP72 abundance was, in part, associated with the cardioprotective phenotype observed in this study.
Introduction
Chronic hypertension is a major risk factor for the development of coronary artery disease and is a well-documented precursor for the development of congestive heart failure (24). Chronic hypertension induces pathological, concentric hypertrophy in which there is a parallel addition of sarcomeres that characteristically increases cardiomyocyte cell size and width (21). From a cellular perspective concentric hypertrophy differs from eccentric hypertrophy in that with eccentric hypertrophy, cardiomyocytes adapt by increasing sarcomeres in series thereby inducing an increase in cell length (21, 52). While compensatory concentric hypertrophy is often regarded as an adaptational process to normalize wall stress with hypertension (68) , it is frequently manifest with normal or hyperactive systolic performance coupled with diastolic dysfunction, i.e. increased LV chamber stiffness (16) and an increased susceptibility to ischemia/reperfusion injury (3,
5, 17, 23, 32, 60, 69, 70, 71).
In general, chronic aerobic exercise training has been shown to protect the myocardium from ischemia/reperfusion injury (64, 74). Several studies have shown that training protects the myocardium from hypoxia, anoxia and ischemia/reperfusion injury (6, 7, 10, 11, 14, 15, 36, 37, 39, 41, 44,46, 47, 50, 55, 63) with higher intensities of exercise shown to confer greater protection (10, 11, 44) . Understanding the mechanisms associated with exercise-induced cardioprotection from ischemia/reperfusion injury has great clinical relevance. Exercise training has been shown to enhance myocardial antioxidant scavenging (20, 44, 62) and increases the expression of ~70-to 72-kDa heat shock proteins (HSP72), an effect that can occur within a few days after the onset of training (20, 47, 54, 56). The HSP70/72 -kDa family are associated with a host of protective mechanisms including stabilizing and refolding damaged proteins during stressful conditions like ischemia. It has been suggested that HSP72 protection from ischemia/reperfusion injury is, in part, mediated via its effects on ATP-sensitive K + channels (34).
Few data exist with respect to how chronic exercise training impacts ischemia/reperfusion tolerance in compensated hypertrophy. Thus, the purpose of the present study was to examine whether exercise training superimposed on a model of pressure overload hypertrophy was protective against ischemia-reperfusion injury. Our specific hypothesis was that four months of aerobic exercise training (treadmill running) in the spontaneously hypertensive rat (SHR) model would improve left ventricular performance in response to a relative bout of hypoperfusion followed by reperfusion, and that this putative effect would be related to the post-reperfusion abundance of myocardial 72-kDa heat shock proteins.
Methods

Animals and Exercise Training
Forty, Four month old female Wistar Kyoto WKY (n=20) and SHR (n=20) (weighing approximately 185 grams) were obtained from Charles River Laboratories (StConstant, Quebec, Canada). Animals within both the WKY and SHR group were randomly assigned into either a sedentary (WKY-SED, N=10; SHR-SED, N=10) or exercise-trained group (WKY-TRD, N=10; SHR-TRD, N=10). All rats were housed 3 per cage, maintained on a 12-h light/dark cycle, and fed ad libitum (Harlan Teklad Global Diets, 18% Protein Diet, Madison, WI). Training consisted of low intensity endurance training at a speed of 25 m/min, 0% grade, 60 continuous minutes, 5 days/week for a period of 16-weeks. SHR-SED and WKY-SED were handled each day. Resting heart rates (mean of 25 cardiac cycles) and blood pressures were collected on three occasions 
Isolated rat heart preparation
Rats were anesthetized with sodium pentobarbital (60 mg/kg; IP) and heparinized intravenously (500 U; IV). The heart was excised, trimmed of excess tissue, and rapidly immersed in cold (4°C), Ca 2+ -free Krebs-Henseleit buffer (KHB). Hearts were placed on a Langendorff perfusion apparatus (ML785B2, ADInstruments, Colorado Springs, CO) and perfused at 16 ml/min (STH pump controller ML175, ADInstruments, Colorado Springs, CO) with a modified Krebs-Henseleit solution containing in mM; 2.0 Ca 2+ Cl 2 , 130 NaCl, 5.4 KCL, 11 dextrose, 2 pyruvate, 0.5 MgCl 2 , 0.5 NaH 2 PO 4 , 25 NaCHO 3 . The buffer was equilibrated with 95% O2 and 5% CO2 which maintained the pH at 7.35-7.4 as previously described (49).
The coronary flow rate was selected to mimic the in situ perfusion pressure. After coronary perfusion was initiated, the left ventricle was immediately decompressed with an apical puncture via the insertion of a short apical drain. A balloon was inserted into the LV and the LV balloon volume was adjusted to 10-12 mmHg of LV end-diastolic pressure (LVEDP) for stabilization. Following stabilization no further alterations in balloon volume were made and pre-ischemic baseline LV performance was recorded.
After baseline measurements, a relative period of hypoperfusion was established by reducing the coronary flow by 75% of baseline to 4 ml/min. The hypoperfusion flow was designed to mimic clinical coronary syndromes in which coronary lesions often become significant when flow is compromised in excess of 70%. Hypoperfusion, as opposed to no-flow ischemia, allows the heart to continue working through the period of compromised flow (45). Hypoperfusion was maintained for 17 minutes followed by After the PVDF membranes were blocked with nonfat dry milk, they were incubated with a mouse monoclonal antibody reacting to HSP72 (Stressgen Bioreagents). The secondary antibody, a horseradish peroxidase-conjugated rabbit, anti-mouse immunoglobin G (Jackson ImmunoResearch Laboratories) was then applied. The membranes were developed using enhanced chemiluminescence and exposed to X-ray film. The membrane was then stripped using 5X Western Reprobe buffer. Following the recommended washing and blocking, the PVDF membrane was then incubated with a antibody reacting to GAPDH. The application of the secondary antibody and membrane development was performed as previously described. HSP72 and GAPDH were then quantified by densitometry.
Data Analysis
Animal characteristics and hemodynamics at time of sacrifice were compared with one-way analysis of variance (ANOVA) and least significant difference (LSD) post hoc analysis. LV performance during hypoperfusion/reperfusion performance was analyzed with ANOVA with repeated measures and Tukey post hoc analysis.
Myocardial HSP72 protein abundance was compared using a one-way ANOVA and Tukey post hoc analysis. Pearson-Product correlations were performed for LV functional recovery and HSP72 protein abundance. All analyses were performed using SPSS version 12.0 (Chicago, IL). Significance was set at an alpha level of P < 0.05. Statistical tendencies are reported as P<0.1. Data are reported as the mean + SEM. Langendorff hearts with significant arrhythmias and/or technical limitations were not included in the final data analysis. The final group sample size for isolated heart studies were as follows:
(WKY-SED, N=8; WKY-TRD, N=9; SHR-SED, N=7; SHR-TRD, N=8).
Results
Hemodynamics.
Following 16 weeks of exercise training, resting HR values for both WKY-TRD and SHR-TRD were significantly lower than their respective sedentary controls (WKY-SED and SHR-SED) ( Table 1 ). WKY-TRD had a lower HR than both SHR groups (P < 0.01). Systolic blood pressure (SBP) gradually increased over time in all groups and immediately prior to sacrifice, SBP, diastolic blood pressure (DBP), mean arterial pressure (MAP) and RPP were significantly greater in both SHR groups relative to both WKY groups. Training-induced bradycardia in SHR-TRD attenuated the RPP relative to SHR-SED (P<0.05), whereas RPP was similar between WKY-SED and WKY-TRD.
Animal Characteristics.
The animal physical characteristics are presented in Table 2 . At the time of sacrifice the body weights of both SHR groups were less than that of both WKY groups (P<0.01). Absolute heart weight (HW) was greater in SHR-TRD vs. WKY-SED (P<0.01). HW/BW ratio was greater in both groups of SHR relative to both groups of WKY (P<0.001). Absolute tibial length was similar among all groups. However, SHR-TRD showed a greater heart weight to tibial length ratio relative to both WKY-SED and WKY-TRD (P<0.05).
Isolated Heart Performance
In our model, all hearts were perfused at a constant coronary flow rate of 16 ml/min with a crystalloid perfusate, allowing for differences in coronary perfusion pressure to be illustrative of coronary vascular resistance. As table 3 illustrates, the baseline coronary flow rate of 16 ml/min elicited similar perfusion pressures between both WKY groups despite the tendency for coronary perfusion pressure to be greater in both SHR groups relative to both groups of WKY. At baseline, LV end-diastolic volume was experimentally fixed to yield an LV end-diastolic pressure (LVEDP) of 10-12 mmHg. Mean LV balloon volume was similar in WKY compared to SHR (WKY-SED: 48 ± 7 μl, WKY-TRD: 52 ± 5 μl, SHR-SED: 65 ± 14 μl, and SHR-TRD: 62 ± 15 μl; P = NS). Baseline Langendorff LV performance was similar across all groups. Tables 3 and 4 LV developed pressure fell approximately 80% in all groups during hypoperfusion and was greater (both relative and absolute; P<0.05) in SHR-SED and SHR-TRD relative to WKY-SED midway through hypoperfusion. LVEDP, +dP/dt, and -dP/dt were similar between groups during hypoperfusion. Reperfusion improved cardiac performance relative to hypoperfusion. However, throughout reperfusion absolute and relative LV developed pressure, +dP/dt and -dP/dt (Tables 3 and 4) were most compromised in WKY-SED relative to all of the other groups.
HSP 72 Abundance
The HSP72/GAPDH abundance is illustrated in Figure 1 . HSP72/GAPDH abundance was increased in WKY-TRD relative to WKY-SED (P < 0.05). Both SHR groups showed greater HSP72/GAPDH relative to WKY-SED (P < 0.01). Moreover, both absolute and relative LV developed pressure recovery were well-correlated with HSP72/GAPDH abundance (R 2 =0.86, P<0.0001; R 2 =0.60, P<0.0004, absolute and relative respectively) ( Figure 2 ).
Discussion
The major findings of this study are that in the compensated hypertrophy stage, hearts from SHR animals were more tolerant to hypoperfusion followed by reperfusion.
In normotensive WKY animals, endurance training also provided protection from hypoperfusion /reperfusion contractile dysfunction. However, moderate intensity endurance training superimposed on hypertension conferred no further cardioprotection from hypoperfusion/reperfusion. Post-reperfusion HSP72 abundance was enhanced with both hypertension-induced compensated hypertrophy and endurance training, and was well-correlated with LV functional recovery during reperfusion. These data suggest that an increased post-reperfusion HSP72 abundance is, in part, associated with the cardioprotective phenotype that accompanies short-term hypertension and exercise training. There is an abundance of literature suggesting that HSP 72 is not an essential component for cardioprotection (4, 18, 29, 42, 57, 58, 65, 66, 75, 76, 77, 83, 84) .
However, the HSP70/72 -kDa family is associated with a host of protective mechanisms including stabilizing and refolding damaged proteins during ischemic stress (26, 28, 31, 40, 73) and, it is possible that the increased post-reperfusion abundance of HSP72
observed in the present study may in part, mechanistically explain the protection observed in WKY-TRD and both groups of SHR.
.
Although not determined in the present study, exercise training has also been shown to maintain ATP and PCr content in response to ischemia/reperfusion (10, 11), improve SR Ca 2+ transport (59), and up-regulate some key glycolytic enzymes (38, 44).
ATP is functionally important in protection from ischemia-reperfusion injury, in part, by maintaining ionic balance (19, 35). ATP derived from glycolytic metabolism (19) is thought to preferentially fuel Ca 2+ uptake by the sarcoplasmic reticulum (82), the Na However, these previous studies typically examined older animals at accelerated phases in the hypertensive pathophysiologic cascade. Conversely, studies using relatively young animals during the compensated phase of hypertrophy, have shown that the hypertrophied heart is instead more tolerant to ischemia and reperfusion secondary to phenotypical changes which allow the myocardium to be more efficient (78) and tolerant to hypoxic/ischemic stress (25, 30, 72). Tubau et al, suggested that myosin isozyme shifts (from V1 to V2 and V3) with pressure overload may, in part, mechanistically lead to enhanced mechanical efficiency (78).
The results of the present study show that short term compensated hypertrophy in the SHR model is protective from hypoperfusion followed by reperfusion. Once again, the finding that post-reperfusion HSP72 abundance was increased in SHR may, in part, explain the observed putative protection. An enhanced abundance of HSP72 in the SHR model is consistent with previous reports showing enhanced HSP72 levels in response to heat stress (9, 28).
Interestingly, although our results show that exercise training resulted in greater hypoperfusion/reperfusion contractile performance in WKY-TRD relative to WKY-SED, exercise training superimposed upon hypertension did not provide any additional protective effects. The comparable performance between the trained and untrained hypertensive groups is difficult to explain and contrary to our initial hypothesis. One possibility is that the low intensity training protocol utilized in this study was not a sufficient enough stimulus to elicit a cardioprotective phenotype in the already compensated SHR myocardium. We chose the training intensity of 55% V0 2 peak to correspond to the preferred training intensity for hypertensive patients (1) and our initial studies in the SHR model have shown that this intensity was effective in improving tolerance to acidosis (67) and enhancing beta adrenergic responsiveness and signaling (49).
The SHR model was selected for our study because it closely mimics the clinical course of untreated essential hypertension in humans. It has been documented that concentric hypertrophy occurs in SHR between 6 and 12 months of age, decompensating to heart failure near 15 months (8) . We chose to study these animals at 8 months of age because compensatory hypertrophy is known to exist at this age without a concomitant increase in interstitial fibrosis (8) . The causes of hypertension in SHR are polygenic and do not necessarily reflect the genetic anomalies associated with hypertension in humans.
Despite this limitation, the present data suggests that both exercise training and shortterm hypertension protects the heart from hypoperfusion/reperfusion with no further putative effect gained by superimposing exercise training on hypertension. Our data also suggests that the post-reperfusion abundance of HSP72 plays a role in this enhanced tolerance to hypoperfusion/ reperfusion. 
